A clinicopathological study has demonstrated that expression of HIF‐1α was observed in 83% (35/42) of RB tumors, which clearly shows that hypoxic pathway is activated in majority of the RB tumors (13). The gene discussed is HIF1A; the disease is retinoblastoma.